Spectrum of cutaneous adverse drug reactions seen in the Emergency Department (ED): A prospective study from Kuwait

Middle East Journal of Emergency Medicine

Volumn 6, Issue 2, 2006, Pages 11-15

  Al Ghanem, Faisal ^b   Al Mutairi, N ^a  

^a Al Farwaniya Hospital   (Kuwait)

^b NONE   (Kuwait)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ANALGESIC AGENT; ANTICONVULSIVE AGENT; ANTIINFECTIVE AGENT; ANTIMALARIAL AGENT; ANTIPYRETIC AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CARBAMAZEPINE; CENTRAL NERVOUS SYSTEM AGENTS; CEPHALOSPORIN; CHLORMEZANONE; COTRIMOXAZOLE; DAPSONE; ERYTHROMYCIN; IBUPROFEN; MACROLIDE; NITROFURANTOIN; NONSTEROID ANTIINFLAMMATORY AGENT; PENICILLIN G; PHENOBARBITAL; PHENYTOIN; PIROXICAM;

ADOLESCENT; ADULT; AGED; ANGIONEUROTIC EDEMA; ARTICLE; CHILD; CLINICAL EXAMINATION; CONTROLLED STUDY; DISEASE SEVERITY; DRUG ERUPTION; DRUG HYPERSENSITIVITY; EMERGENCY WARD; ERYTHEMA MULTIFORME; ERYTHRODERMA; EYE DISEASE; FEMALE; FEVER; FIXED DRUG ERUPTION; HUMAN; INFANT; KIDNEY DISEASE; KUWAIT; LABORATORY TEST; LICHENOID ERUPTION; MAJOR CLINICAL STUDY; MALE; PHOTOSENSITIVITY DISORDER; PHYSICAL EXAMINATION; PRACTICE GUIDELINE; RASH; SEPTICEMIA; SKIN MANIFESTATION; STEVENS JOHNSON SYNDROME; SYSTEMIC DISEASE; THRUSH; TOXIC EPIDERMAL NECROLYSIS; TREATMENT DURATION; UNSPECIFIED SIDE EFFECT; URINARY TRACT INFECTION; URTICARIA; VESICULAR RASH;

EID: 33751325060     PISSN: 17296455     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (19)

1. Requirements for adverse drug reaction reporting. Geneva: World Health Organization, 1975.
2. American Society of Hospital Pharmacy. ASHP guidelines on adverse drug reaction monitoring and reporting. Am J Health Syst Pharm 1995; 52:417-9.
3. Yawalkar N. Drug induced exanthems. Toxicology, 2005;209:131-134.
4. Bischer AJ. Symptoms and danger signs in acute drug hypersensitivity. Toxicology, 2005;209:201-207.
5. Goldman SA, Kennedy DL, Lieberman R, eds. Clinical therapeutics and the recognition of drug-induced disease. Rockville, Md.: U.S. Food and Drug Administration, June 1995.
6. Bigby M. Rates of cutaneous reactions to drugs. Arch Dermatol, 2001;137:765-770.
7. Bork K. Etiologic reaction patterns in drug intolerance. In: Bork K, ed. Cutaneous side effects of drugs. Philadelphia: W. B. Saunders company, 188: 17-25.
8. Sacerdots G, Vozza A, Ruocco V. Identifying skin reactions to drugs. Int J Dermatol 1993; 12:469-479.
9. Hendrick AE, McCarthy MW, Hofer K. University of Virginia Health System Adverse Drug Reaction Reporting Program Policy and Procedure. University of Virginia Health System. Department of Pharmacy Services, Drug Information Center. 1-5-99. http://hsc.virginia.edu/ pharmacyservices/ADRRP/ADR-P&P. html. Accessed on 8-13-2003.
10. Kauppinen K, Alanko K. Oral provocation: uses. Semin Dermatol 1989; 8, No 3: 192-195.
11. Sushma M, Noel MV, Ritika MC, Guido S. Cutaneous adverse drug reactions: a 9-year study from a South Indian Hospital. Pharmacoepidemiol Drug Saf, 2005;14(8):567-570.
12. Sharma VK, Sethuraman C, Kumar B. Cutaneous adverse drug reactions: Clinical pattern and causative agents-A six-year series from Chandigarh, India. J Postgrad Med 2001; 47: 95-9.
13. Solensky R, Mendelson LM. Systemic reactions to antibiotics. Immunol Allergy Clin N Am 2001; 21:679-97.
14. Hafner JW, Belknap SW, Squillante MD, Bucheit KA. Adverse drug events in emergency department patients. Ann Emerg Med 2002; 39:258-67.
15. Stuhb S, Heikkila H, Kauppinen K. Cutaneous reactions to drugs. A series of in patients during a five-year period. Acta Dermatol Venereal (Stockb) 1994; 74: 289-291.
16. Drake LA, Dinehart SM, Farmer ER, Goltz RW, Graham GF, Hordinsky MK, et al. Guidelines of care for cutaneous adverse drug reactions. American academy of dermatology. J Am Acad Dermatol 1996; 35:458-61.
17. Romagosa R, Kapoor S, Sanders J, Herman B. Inpatient adverse cutaneous drug eruptions and eosinophilia. Arch Dermatol 2001; 137:511-2.
18. Alanko K, Stubb S, Kauppinen K. Cutaneous drug reactions: clinical types and causative agents. A five-year survey of in patients (1981-1985). Acta Dermatol Venereal (Stockb) 1989; 69: 223-226.
19. Puavilai S, Choonhakarn C. Drug eruptions in Bangkok: a 1-year study at Ramathibodi Hospital. Int J Dermatol 1998; 37: 747-751.